Biofrontera Inc. (BFRIW) Return on equity 2020–2025
Biofrontera Inc. (BFRIW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-100.5%FY2025 · since FY2020: -188.5% → -100.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -100.5% | +300.1 pp |
| FY2024 | -400.6% | +19.4 pp |
| FY2023 | -420.0% | -417.3 pp |
| FY2022 | -2.7% | +329.9 pp |
| FY2021 | -332.6% | -144.1 pp |
| FY2020 | -188.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BFRIW financial trends
BFRIW RevenueBFRIW Net incomeBFRIW Net marginBFRIW Gross profitBFRIW Gross marginBFRIW Operating incomeBFRIW Operating marginBFRIW Operating cash flowBFRIW Free cash flowBFRIW Capital expendituresBFRIW Stock buybacksBFRIW Dividends paidBFRIW Total assetsBFRIW Total liabilitiesBFRIW Shareholders’ equityBFRIW overview →